The antimicrobial activity of hexane, chloroform, ethyl acetate and ethanol extracts of the aerial parts of S. sandrasicus P.H.Davis (Asteraceae), endemic to Sandras mountain (Turkey), were determined. The antimicrobial activity of the extracts on microorganisms including multi-resistant staphylococci were evaluated using the disc diffusion method. The strains of multi-resistant staphylococci and the other standart bacteria were inhibited by some extracts. The volatile organic compouds of S. sandrasicus was determined by Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometry (GC-MS). The major compounds of hexane extract were aromadendrene oxide 2 (13.3%), spathulenol (12.5%) and β-caryophylene (11.8%), respectively.
In the last decades, the spread of antibiotic resistance in bacteria, including staphylococci, is increasing and may represent a hazard for human health [1a] . Staphylococci are responsible for a plethora of medical problems, including skin and softtissue infections, surgical site infections, endocarditis and hospital acquired bacteraemia [1b] . Some staphylococcal species, such as Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus saprophyticus, are well known for their implications in human health diseases [1c] . Coagulase-positive S. aureus is a major cause of nosocomial infections, food poisoning, osteomyelitis, pyoarthritis, endocarditis, toxic shock syndrome, and a broad spectrum of other disorders [2a,2b] . Coagulase-negative staphylococci (CNS) include S. epidermidis, Staphylococcus haemolyticus, S. saprophyticus and a number of other species [2c] . In recent years, several species of CNS have been recognized as opportunistic pathogens and have been implicated in human infections and disease, especially in immunocompromised and seriously ill patients [2d].
Among antibiotic resistant staphylococci, multidrugresistant S. aureus strains are of great public concern since resistances make more difficult the treatment of infections. Moreover, a number of CNS, such as several S. epidermidis strains, are important hospitalacquired infection agents and the 80-90% of these isolates are methicillin-resistant [1a] .
The development of resistance by a pathogen to many of the commonly used antibiotics provides an impetus for further attempts to find new antimicrobial agents to combat infections and overcome problems of resistance and side effects of the currently available antimicrobial agents [3a,3b] *Antibiotic resistance patterns of Staphylococci determined according to the recommendations NCCLS. P: Penicillin-G (10 U); AK: Amikacin (30µg); DA: Clindamycin (2 µg); E: Erythromycin (15 µg); CN: Gentamicin (10 µg); C: Chloramphenicol (30 µg); ME: Methicillin (5 µg); OX: Oxacillin (1 µg); TEC: Teicoplanin (30 µg); TE: Tetracycline (30 µg). These extracts demonstrated various antimicrobial activities on tested bacteria. The two different doses of all extracts have not effects on S. mutans, S. epidermidis MU 30 and yeasts. The inhibition zones of bacterial strains, sensitive to the 0.4 and 3.6 μg extracts of S. sandrasicus, were in the range of 7-15 and 10-18 mm, respectively. As it can be seen from Table 2 and 3, when the doses of extracts were increased by 9-fold, the antimicrobial activities of extracts were also increased. However, the increase on antimicrobial activities were not as much as the increase in doses of extracts.
The ethanol, hexane, chloroform and ethyl acetate extracts demonstrated antibacterial activities on Staphylococcus strains which shows resistance to various antibiotics. All the extracts had no effect on S. epidermidis MU 30. The hexane extract inhibited the growth of all multi-resistant Staphylococcus were identified by comparison with reference substances, NIST 2002, Wiley and locally constructed libraries. The major compounds of hexane extract of this plant were found to be aromadendrene oxide 2 (13.3%), spathulenol (12.5%), β-caryophylene (11.8%), caryophyllene oxide (11.6%), α-cadinol (6.3%) (see Table 4 ). The hexane extract comprised 69.3% sesquiterpenoids. The antimicrobial activities of aromadendrene oxide 2, spathulenol and caryophyllene oxide are known [7] [8] [9] . These are thought to be responsible for the S. sandrasicus high antimicrobial activity. . MRSA is currently recognized as a major problem in hospitals and the broader community in the United States and throughout the world [11] . MRSA strains are often resistant to antimicrobials other than β-lactams, thereby limiting the range of therapeutic options and increasing the risk of treatment failure as well as the costs for antimicrobial therapy and hospitalization [12] . There is an established need to develop new antimicrobial agents to combat these pathogens [5a,13] 
Disc diffusion assay:
The antibacterial activity was evaluated using accepted disc diffusion methodology [15a-15c] using bacterial cell suspension whose concentration was equilibrated to a 0.5 McFarland standard. A 100 μL of each bacterial suspension was spread on a Mueller-Hinton agar plate. Twenty-five µL of each extract containing 0.4 μg and 3.6 μg crude extract were injected in discs of 6 mm in diameter (Schleicher & Schuell). The discs were allowed to dry and then placed on the inoculated agar. The plates were incubated at appropriate temperature and time for microorganisms. Discs of hexane, chloroform, ethanol, ethyl acetate were used as controls. After the prerequisite incubation time a zone of inhibition was measured. The experiment was performed in triplicate and the average values are presented.
Column chromatography (CC): Firstly, CC was performed to highlight the structure of the active extract. For CC, silica-gel 60 (70-230 mesh) as adsorbent in a column with 2x80 cm measurements was used and mobile phases were respectively 95:5, 90:10 and 85:15 hexane: acetone systems. The fractions were purified by TLC and subjected to GC and GC-MS analysis.
Gas chromatography (GC): GC analyses of the extract was performed using a Shimadzu GC-17 AAF, V3, 230V LV series gas chromatograph equipped with a FID and a DB-5 fused silica capillary column (30 m x 0.32 id., film thickness 0.25 µm); the initial oven temperature was held at 100 o C for 5 min, then programmed to 240 o C at 3 o C/min and held at this temperature for 30 min; injector temperature and detector temperature was 250 and 270 o C, respectively; carrier gas was He at a flow rate of 1.4 mL/min; sample size, 1.0 µL; split ratio, 50:1. The percentage composition of the hexane extract was determined with Class-GC 10 computer program.
Gas Chromatography -Mass Spectrometry (GC-MS): 50 mg/mL solution of the bioactive hexane extract was prepared for GC and GC-MS analyses. The analysis of the extract was performed using a Varian Saturn 2100, (E.I Quadrupole) equipped with a DB-5 MS fused silica capillary column (30 m x 0.32 mm id., film thickness 0.25 µm). For GC-MS detection, an electron ionization system with ionization energy of 70 eV was used. Carrier gas was helium at a flow rate of 1.7 mL/min. Injector and MS transfer line temperatures were set at 220 o C and 290 o C, respectively. The oven temperature was held at 100 o C for 5 min, then increased up to 240 o C with 3 o C/min increases and held at this temperature for 25 min. Diluted samples (1/100, v/v, in methylene chloride) of 1.0 mL were injected manually in the splitless mode. The relative percentage of the extract constituents was expressed as percentages by peak area normalization.
Identification of components of the extract was computer matching of mass spectra with those of standards (NIST 2002, Wiley library data of GC-MS systems and a locally customized library of 320 spectra), as well as by comparison with the fragmentation patterns of the mass spectra with those reported in the literature [15d] and, whenever possible, by co-injection with authentic compounds.
